Young James Emmett bought TLSI
January 27, 2025 · Form 4 insider transaction
Young James Emmett bought 24,000 shares of TriSalus Life Sciences, Inc. at $5.40 per share, a transaction worth $129.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.; The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.